PuraPly® Antimicrobial (PuraPly AM) Wound Matrix is an FDA 510(k)-cleared Class II medical device that is indicated for the management of a variety of surgical wounds.
Launched in 2016, PuraPly AM is an essential part of BBWM, a proactive approach which aims to reduce bioburden and manage the reformation of biofilm with sharp debridement and the use of PuraPly AM.
PuraPly AM is intended for the management of surgical wounds and as an effective barrier to resist microbial colonization within the device and reduce microbes penetrating through the device.
- Surgical wounds
- Donor sites/grafts
- Post-Mohs surgery
- Post-laser surgery
PuraPly AM Provides Clinical Benefit in 3 Ways:
- Purified Type 1 native collagen matrix creates a durable biocompatible scaffold
- Effective barrier against a wide array of microorganisms
- PHMB is known to inhibit the formation of biofilm on the wound surface